Citations

Citations to this article as recorded by  

• Diagnostic Approach to Biliary Strictures
  Daniyal Raza, Sahib Singh, Stefano Francesco Crinò, Ivo Boskoski, Cristiano Spada, Lorenzo Fuccio, Jayanta Samanta, Jahnvi Dhar, Marco Spadaccini, Paraskevas Gkolfakis, Marcello Fabio Maida, Jorge Machicado, Marcello Spampinato, Antonio Facciorusso
  Diagnostics.2025; 15(3): 325.     CrossRef
• Artificial intelligence for automatic diagnosis and pleomorphic morphological characterization of malignant biliary strictures using digital cholangioscopy
  Miguel Mascarenhas, Maria João Almeida, Mariano González-Haba, Belén Agudo Castillo, Jessica Widmer, António Costa, Yousef Fazel, Tiago Ribeiro, Francisco Mendes, Miguel Martins, João Afonso, Pedro Cardoso, Joana Mota, Joana Fernandes, João Ferreira, Fili
  Scientific Reports.2025;[Epub]     CrossRef
• Case report: The diagnostic dilemma of indeterminate biliary strictures: report on two cases with a literature review
  Chunyan Meng, Jing Wang, Peipei Zhang, Bo Wang
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Clinical application of fly-thru in diagnosis of biliary obstructive diseases: feasibility, reproducibility, and diagnostic value
  Tongyi Huang, Zebang Yang, Xiaoli Wang, Jiaqian Yao, Lin Jiang, Xiaoyan Xie, Ming Xu, Xiaoer Zhang
  Abdominal Radiology.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Effects of antithrombotic therapy on bleeding after endoscopic sphincterotomy: A systematic review and meta-analysis
  Gang Huang, Feng-Yu Tian, Wen An, Li-Si Ai, Yan-Bo Yu
  Endoscopy International Open.2022; 10(06): E865.     CrossRef

The most common form in bile duct cancers is a highly desmoplastic cancer with a growth pattern characterized by periductal extension and infiltration. The prognosis of bile duct cancers, especially hilar cholangiocarcinoma, is limited by tumor spread along the biliary tree leading to refractory obstructive cholestasis, cholangitis, and liver failure. Although biliary endoprosthesis improves occlusion rates and reduces the number of therapeutic interventions, median survival time is not ameliorated. Photodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photosensitizing agent in combination with laser irradiation of a distinct wavelength. Tumor ablation with PDT combined with biliary stenting reduces cholestasis and significantly improves median survival time in selected patients with bile duct cancers.

Citations

Citations to this article as recorded by  

• The Photosensitizer Temoporfin (mTHPC) – Chemical, Pre‐clinical and Clinical Developments in the Last Decade†‡
  Arno Wiehe, Mathias O. Senge
  Photochemistry and Photobiology.2023; 99(2): 356.     CrossRef
• Inhibition of hypoxia-inducible factor 1 by acriflavine renders glioblastoma sensitive for photodynamic therapy
  Shuai Ma, Fang Wang, Jiawei Dong, Nan Wang, Shengzhong Tao, Jianyang Du, Shaoshan Hu
  Journal of Photochemistry and Photobiology B: Biology.2022; 234: 112537.     CrossRef
• Extrahepatic cholangiocarcinoma: Current status of endoscopic approach and additional therapies
  Alina Ioana Tantau, Alina Mandrutiu, Anamaria Pop, Roxana Delia Zaharie, Dana Crisan, Carmen Monica Preda, Marcel Tantau, Voicu Mercea
  World Journal of Hepatology.2021; 13(2): 166.     CrossRef
• Investigated spectral-fluorescent properties of endogenous porphyrins of the wild boar hepatobiliary system optimize the diagnostics and treatment of cholangiocarcinoma with FD and PDT
  Artem Shiryaev, Polina Alekseeva, Kanamat Efendiev, Dmitry Yakovlev, Arkadii Moskalev, Elizaveta Kozlikina, Pavel Kharnas, Igor Reshetov, Vladimir Levkin, Victor Loschenov
  Optical Engineering.2020; 59(06): 1.     CrossRef
• New approaches to diagnostics and treatment of cholangiocellular cancer based on photonics methods
  Dmitry V. Yakovlev, Dina S. Farrakhova, Artem A. Shiryaev, Kanamat T. Efendiev, Maxim V. Loschenov, Liana M. Amirkhanova, Dmitry O. Kornev, Vladimir V. Levkin, Igor V. Reshetov, Victor B. Loschenov
  Frontiers of Optoelectronics.2020; 13(4): 352.     CrossRef
• Therapy for hilar cholangiocarcinoma
  D. Yu. Frantsev, O. N. Sergeeva, B. I. Dolgushin
  Siberian journal of oncology.2019; 18(1): 103.     CrossRef
• Combined treatment of nonresectable cholangiocarcinoma complicated by obstructive jaundice
  A.A. Shiryaev, G.Kh. Musaev, V.V. Levkin, I.V. Reshetov, M.V. Loshchenov, P.M. Alekseeva, V.V. Volkov, K.G. Linkov, V.I. Makarov, I.O. Shchekoturov, A.V. Borodkin, V.B Loschenov
  Photodiagnosis and Photodynamic Therapy.2019; 26: 218.     CrossRef
• Local Therapy in Advanced Cholangiocarcinoma: A Review of Current Endoscopic, Medical, and Oncologic Treatment Options
  Carlo Felix Maria Jung, Julie Lavole, Maximilien Barret, Einas Abou Ali, Lola-Jade Palmieri, Solene Dermine, Amélie Barré, Stanislas Chaussade, Romain Coriat
  Oncology.2019; 97(4): 191.     CrossRef
• Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: A feasibility study
  Luciano Tarantino, Giuseppina Busto, Aurelio Nasto, Riccardo Aurelio Nasto, Paolo Tarantino, Raffaele Fristachi, Luigi Cacace, Sara Bortone
  European Journal of Surgical Oncology.2018; 44(10): 1603.     CrossRef
• Clinico-pathological factors and prognosis scale for portal cholangiocarcinoma
  Yu. O. Zharikov, Yu. A. Kovalenko, A. A. Olifir, D. V. Kalinin, A. V. Czhao
  Khirurgiya. Zhurnal im. N.I. Pirogova.2017; (1): 27.     CrossRef
• Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids
  Anne-Laure Bulin, Mans Broekgaarden, Tayyaba Hasan
  Scientific Reports.2017;[Epub]     CrossRef
• Redox-Responsive Nanophotosensitizer Composed of Chlorin e6-Conjugated Dextran for Photodynamic Treatment of Colon Cancer Cells
  Chong Woo Chu, Je Ho Ryu, Young-IL Jeong, Tae Won Kwak, Hye Lim Lee, Hyun Yul Kim, Gyung Mo Son, Hyung Wook Kim, Dae Hwan Kang
  Journal of Nanomaterials.2016; 2016: 1.     CrossRef
• Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy
  M. Broekgaarden, R. van Vught, S. Oliveira, R. C. Roovers, P. M. P. van Bergen en Henegouwen, R. J. Pieters, T. M. Van Gulik, E. Breukink, M. Heger
  Nanoscale.2016; 8(12): 6490.     CrossRef
• Endoscopic management of hilar stricture
  Abhishek Gulati, Payal Thakkar, Shyam Thakkar
  Techniques in Gastrointestinal Endoscopy.2016; 18(2): 67.     CrossRef
• Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma
  A Schmidt, M Bloechinger, A Weber, J Siveke, S von Delius, C Prinz, W Schmitt, RM Schmid, B Neu
  United European Gastroenterology Journal.2016; 4(4): 570.     CrossRef
• Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies
  E. Una Cidon
  Clinical Medicine Insights: Oncology.2016;[Epub]     CrossRef
• Radiological interventions in malignant biliary obstruction
  Kumble Seetharama Madhusudhan, Shivanand Gamanagatti, Deep Narayan Srivastava, Arun Kumar Gupta
  World Journal of Radiology.2016; 8(5): 518.     CrossRef
• Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy
  Ruud Weijer, Mans Broekgaarden, Massis Krekorian, Lindy K. Alles, Albert C. van Wijk, Claire Mackaaij, Joanne Verheij, Allard C. van der Wal, Thomas M. van Gulik, Gert Storm, Michal Heger
  Oncotarget.2016; 7(3): 3341.     CrossRef
• Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis
  Yi Lu, Lei Liu, Jia-chuan Wu, Li-ke Bie, Biao Gong
  Clinics and Research in Hepatology and Gastroenterology.2015; 39(6): 718.     CrossRef
• Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies
  Mans Broekgaarden, Ruud Weijer, Thomas M. van Gulik, Michael R. Hamblin, Michal Heger
  Cancer and Metastasis Reviews.2015; 34(4): 643.     CrossRef
• Biliary Tumor Ablation with Photodynamic Therapy and Radiofrequency Ablation
  Ioana Smith, Michel Kahaleh
  Gastrointestinal Endoscopy Clinics of North America.2015; 25(4): 793.     CrossRef
• Nanoparticulate carriers for photodynamic therapy of cholangiocarcinoma: In vitro comparison of various polymer-based nanoparticles
  Jonas Grünebaum, Judith Söbbing, Dennis Mulac, Klaus Langer
  International Journal of Pharmaceutics.2015; 496(2): 942.     CrossRef
• Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride
  Ling Cheng, Ping-hua Xu, Bao-de Shen, Gang Shen, Juan-juan Li, Ling Qiu, Chao-yong Liu, Hai-long Yuan, Jin Han
  International Journal of Pharmaceutics.2015; 489(1-2): 148.     CrossRef
• Role of photodynamic therapy and intraductal radiofrequency ablation in cholangiocarcinoma
  Janaki Patel, Nada Rizk, Michel Kahaleh
  Best Practice & Research Clinical Gastroenterology.2015; 29(2): 309.     CrossRef
• Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies
  N. Schweitzer, A. Vogel
  Best Practice & Research Clinical Gastroenterology.2015; 29(2): 345.     CrossRef
• Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells
  Ruud Weijer, Mans Broekgaarden, Rowan F. van Golen, Esther Bulle, Esther Nieuwenhuis, Aldo Jongejan, Perry D. Moerland, Antoine H. C. van Kampen, Thomas M. van Gulik, Michal Heger
  BMC Cancer.2015;[Epub]     CrossRef
• Endoscopic and Percutaneous Approaches to the Treatment of Biliary Tract and Primary Liver Tumors
  Kevin N. Shah, Bryan M. Clary
  Surgical Oncology Clinics of North America.2014; 23(2): 207.     CrossRef
• Palliation: Hilar cholangiocarcinoma
  Mahesh Kr Goenka, Usha Goenka
  World Journal of Hepatology.2014; 6(8): 559.     CrossRef
• Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells
  Hye Myeong Lee, Young-Il Jeong, Do Hyung Kim, Tae Won Kwak, Chung-Wook Chung, Cy Hyun Kim, Dae Hwan Kang
  International Journal of Pharmaceutics.2013; 454(1): 74.     CrossRef